Canada, Hong Kong paired up in TCM
Signing of Four MOUs a Major Step Forward in Cooperation
HK gov release – Chinese medicine received a significant shot in the arm today with the signing of four memorandums of understanding between Canadian and Hong Kong institutes.
The four MOUs cover collaboration in the research, technology transfer, commercialisation and promotion of Traditional Chinese Medicine (TCM) and health products in the two markets.
Signed during a luncheon hosted by the Canadian Consulate in Hong Kong and the Hong Kong Trade Development Council (TDC), the agreements bring together:
- The Canadian Health Food Association (CHFA) and the Modernized Chinese Medicine International Association (MCMIA)
- The CHFA and the Hong Kong Health Food Association (HKHFA)
- Canada’s Advanced Foods and Materials Network (AFMNet) and the Hong Kong Jockey Club Institute of Chinese Medicine (HKJCICM)
- Bell Alliance International Inc and Zigen Pharmaceutical Ltd
The MOUs are the result of a Canadian Life Sciences Trade Mission, which has been visiting Hong Kong’s annual International Conference and Exhibition of the Modernization of Chinese Medicine and Health Products (ICMCM) since 2004.
“The trade mission’s objective is to encourage Canadian and Hong Kong partnerships in the life science sectors, including buying and selling, joint ventures and research cooperation,” said Andrew Yui, Director of the TDC’s Toronto office, which has played a key role in organising the missions to Hong Kong.
The MOU between the CHFA and MCMIA supports mutually beneficial developments, particularly in exchanging knowledge and market information and sharing updates on regulatory requirements.
“The new Natural Health Product Regulation opens a clear path for high quality TCM to be introduced to Canada as natural medicine. Similarly, Canadian natural health products can also be introduced to the Greater China region. CHFA and MCMIA members should find plenty of opportunities to do business between Canada and China using Hong Kong as an efficient portal,” said Abraham Chan, President of MCMIA.
The agreement between the CHFA and the HKHFA establishes similar cooperative links, with an emphasis on optimising the resources of both organisations to support mutually beneficial developments and activities.
“The MOU between AFMNet and HKJCICM strengthens scientific and resource planning and technology transfer of R&D deliverables, raising the return on investment from research to applications,” said Dr Rickey Yada, Scientific Director of AFMNet, and Dr Edmund Lee, Executive Director of HKJCICM.
The commercial MOU between Bell Alliance and Zigen creates a long-term partnership between the two parties, particularly in the development of international markets for health products. “Our companies are working closely together to introduce Chinese medicine formulations and active ingredients to Canada, positioning them as pharmaceuticals and natural health products, which are legally recognised as drugs in Canada, rather than health foods or dietary supplements. We hope to leverage on our success in Canada to introduce these products to other countries around the world,” said Albert Wong, Managing Director of Zigen Pharmaceutical Ltd.
“The MOUs are a milestone in the ongoing efforts of the TDC and our consulate to promote Chinese medicine and health foods. We are proud of this development and will ensure that the collaboration continues to build,” said Francois Rivest, Consul and Senior Trade Commissioner of the Canadian Consulate in Hong Kong.